Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Bohlin, SE
Lars Bohlin, Uppsala SE
| Patent application number | Description | Published |
|---|---|---|
| 20090099068 | ON-GROWTH INHIBITING COMPOUNDS - An on-growth inhibiting agent, for the inhibition and/or prevention of on-growth of biological organisms on objects or living beings, includes at least one cyclotide, and a suitable carrier medium. A plant extract containing a mixture of cyclotides is also usable. | 04-16-2009 |
| 20090124634 | Novel dipodazine compounds and applications - The invention relates to a novel class of dipodazine derivatives, suitable for use as surface on-growth inhibiting agents. | 05-14-2009 |
Martin Bohlin, Sodertalje SE
| Patent application number | Description | Published |
|---|---|---|
| 20080269297 | Process for the Preparation of Esomeprazole Non-Salt Form - The present invention relates to a new process for the preparation of new crystal modifications of esomeprazole non-salt form. Further, the present invention also relates to the use of said new crystal modifications for the treatment of gastrointestinal disorders, pharmaceutical compositions containing them as well as the crystal modifications, as such. | 10-30-2008 |
| 20100022610 | New Crystalline Forms - A salt of the compound N-{2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]-1H-benzimidazol-5-yl}ethanesulfonamide, which is an ethanesulphonic acid salt, a sulphuric acid salt, an ethane disulphonic acid salt, a hydrochloric acid salt, a hydrobromic acid salt, a phosphoric acid salt, an acetic acid salt, a fumaric acid salt, a maleic acid salt, a tartaric acid salt, a citric acid salt, a methanesulphonic acid salt, or a p-toluenesulphonic acid salt of said compound. | 01-28-2010 |
| 20100137304 | NOVEL CRYSTALLINE FORMS OF THE ANTI-CANCER COMPOUND ZD1839 - The invention concerns certain crystalline solvates and hydrates of the compound of the Formula I | 06-03-2010 |
Martin Bohlin, Molndal SE
| Patent application number | Description | Published |
|---|---|---|
| 20080269176 | New Salts - There is provided pharmaceutically-acceptable acid addition salts of compounds of formula (I), | 10-30-2008 |
Martin Bohlin, Södertälje SE
| Patent application number | Description | Published |
|---|---|---|
| 20100022610 | New Crystalline Forms - A salt of the compound N-{2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]-1H-benzimidazol-5-yl}ethanesulfonamide, which is an ethanesulphonic acid salt, a sulphuric acid salt, an ethane disulphonic acid salt, a hydrochloric acid salt, a hydrobromic acid salt, a phosphoric acid salt, an acetic acid salt, a fumaric acid salt, a maleic acid salt, a tartaric acid salt, a citric acid salt, a methanesulphonic acid salt, or a p-toluenesulphonic acid salt of said compound. | 01-28-2010 |
Martin Hans Bohlin, Sodertalje SE
| Patent application number | Description | Published |
|---|---|---|
| 20100249196 | Novel Salt Forms Of (2S)-(4E)-N-Methyl-5-[3-(5-Isopropoxypyridin)yl]-4-Penten 2-Amine - Phosphoric acid, edisylic acid (1,2-ethanedisulfonic acid), citric acid, orotic acid (uracil-6-carboxylic acid), R-mandelic acid, sulfuric acid, 1,5-naphthalenedisulfonic acid, D-aspartic acid, and lysine monohydrochloride salts of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine, and methods for their preparation, pharmaceutical compositions comprising said salts, and use, are disclosed. The salts can be administered to patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, to treat and/or prevent such disorders. | 09-30-2010 |
| 20110009647 | Process 054 - The present invention is directed to a process for the preparation of a diastereomerically pure dibenzoyl-L-tartrate salt of a compound of formula (III) | 01-13-2011 |